Ferras Alashkar
Essen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Clonal Dynamics of GPI-Deficient Cells in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH): A Retrospective Follow-Up Analysis.
Journal: European journal of haematology
Published: April 17, 2026
Sickle Cell Disease and Kidney Injury: Circulating Uromodulin Allows Early Tissue Specific Diagnosis and Monitoring of Treatment.
Journal: American journal of hematology
Published: March 17, 2026
Successful Treatment of Aplastic Anemia With Eltrombopag During Pregnancy: A Short Report.
Journal: EJHaem
Published: October 17, 2025
Sutimlimab in Patients With Cold Agglutinin Disease (CAD): Results From a Managed Access Program.
Journal: European journal of haematology
Published: September 09, 2025
Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: final 48-week results from the open-label, randomised, phase 3 APPLY-PNH trial in anti-C5-treated patients and the open-label, single-arm, phase 3 APPOINT-PNH trial in patients previously untreated with complement inhibitors.
Journal: The Lancet. Haematology
Published: January 13, 2025
Demographics, clinical characteristics, and real-world treatment patterns among patients with beta-thalassemia: a retrospective medical record abstraction study.
Journal: Therapeutic advances in hematology
Published: August 08, 2024
Transition in sickle cell disease - recommendations of the transition initiative sickle cell disease
Transition in sickle cell disease - recommendations of the transition initiative sickle cell disease
Journal: Deutsche medizinische Wochenschrift (1946)
Published: April 24, 2024
Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria.
Journal: The New England journal of medicine
Published: March 13, 2024
Long-term outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in a real-world setting.
Journal: European journal of haematology
Published: December 01, 2022
Luspatercept, a two-edged sword in beta-thalassemia-associated paravertebral extramedullary hematopoietic masses (EHMs).
Journal: European journal of haematology
Published: June 23, 2022
Transition in Sickle Cell Disease (SCD): A German Consensus Recommendation.
Journal: Journal of personalized medicine
Published: June 05, 2022
Screening and diagnosis of hemoglobinopathies in Germany: Current state and future perspectives.
Journal: Scientific reports
Published: February 21, 2022
Last Updated: 09/26/2026